Sign in

Filings

Finds words inside filing documents. Searching Processa Pharmaceuticals, Inc.'s filings · 47 documents indexed.

9 documents · 38 matches

  1. PCSA Processa Pharmaceuticals, Inc. 10-K 2026-03-18

    Item 1A. Risk Factors

    going concern is dependent on our ability to obtain the necessary financing to meet our obligations and repay our liabilities
    11 matches in this document

  2. PCSA Processa Pharmaceuticals, Inc. 8-K/A 2026-10-05

    going concern. As discussed in Note 1 to the consolidated financial statements, the Company has incurred net losses since its inception
    8 matches in this document

  3. PCSA Processa Pharmaceuticals, Inc. 10-Q 2026-05-07

    Item 1 · Note 1. Organization and Summary of Significant Accounting Policies

    going concern within one year after the date that these consolidated financial statements are available to be issued. The accompanying
    3 matches in this document

  4. PCSA Processa Pharmaceuticals, Inc. 10-Q 2025-11-06

    Item 1 · Note 1. Organization and Summary of Significant Accounting Policies

    going concern within one year after the date that these consolidated financial statements are available to be issued. The accompanying
    3 matches in this document

  5. PCSA Processa Pharmaceuticals, Inc. 10-Q 2025-08-07

    Item 1 · Note 1. Organization and Summary of Significant Accounting Policies

    going concern within one year after the date that these consolidated financial statements are available to be issued. The accompanying
    3 matches in this document

  6. PCSA Processa Pharmaceuticals, Inc. 10-Q 2025-05-08

    Item 1 · Note 1. Organization and Summary of Significant Accounting Policies

    going concern within one year after the date that these consolidated financial statements are available to be issued. The accompanying
    3 matches in this document

  7. PCSA Processa Pharmaceuticals, Inc. 8-K/A 2026-10-05

    Going Concern
    4 matches in this document

  8. PCSA Processa Pharmaceuticals, Inc. 10-Q 2026-08-14

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation

    going concern. For a discussion of these and all other known risks and uncertainties that could cause actual results to differ
    2 matches in this document

  9. PCSA Processa Pharmaceuticals, Inc. 8-K/A 2026-10-05

    concerns about on-going or proposed clinical trials or non-compliance with specific FDA requirements, and the trials may not begin
    1 match in this document

Page 1 of 1 · 9 documents